Medication Storage and Travel Restrictions as Damages Evidence in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

Medications requiring refrigeration, temperature control, controlled substance documentation, and special transport impose real-world restrictions on a plaintiff's ability to travel, vacation, and live freely. Learn how storage and travel burdens serve as quality-of-life damages evidence.

The medications prescribed after a personal injury do not just require the plaintiff to take pills -- many require specialized storage conditions, temperature control, controlled substance documentation for travel, and logistical planning that restricts the plaintiff's freedom of movement and spontaneity. Refrigerated biologics, temperature-sensitive medications, DEA-scheduled controlled substances with travel documentation requirements, and sharps disposal obligations all impose tangible lifestyle restrictions that the plaintiff did not face before the accident. These restrictions are documented in pharmacy dispensing records, medication package inserts, and federal regulations, making them objective and verifiable damages evidence.

• Many injury medications require refrigeration (2-8 degrees C), room temperature control, light protection, or other specialized storage conditions documented in the package insert
• Controlled substance prescriptions carry federal and state travel restrictions including quantity limits, documentation requirements, and international transport regulations
• LienScripts documents all storage and handling requirements for dispensed medications, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that includes storage and travel impact analysis
• Injectable medications require sharps containers, proper needle disposal, and additional travel planning for medical waste management
• The storage and travel burden amplifies with each additional medication, compounding the restrictions on the plaintiff's freedom of movement

Refrigeration and Temperature Control Requirements

Cold-Chain Medications

Several medication classes commonly prescribed in PI cases require continuous refrigeration:

• CGRP inhibitors (Aimovig, Ajovy, Emgality) -- used for post-traumatic migraine; require refrigeration at 2-8 degrees C
• Certain injectable biologics -- require cold-chain maintenance from pharmacy to patient
• Some compounded preparations -- compounded topical creams or suspensions may require refrigeration

Cold-chain medications impose the following restrictions:

• Home storage: Dedicated refrigerator space; medications cannot be left on countertops or in medicine cabinets
• Travel: Require insulated travel cases with cold packs; limited time outside refrigeration (typically 7-14 days)
• Spontaneous travel: Cannot leave home for extended periods without planning medication transport and cold storage at the destination
• Power outages: Medication may be compromised if home power is lost for extended periods

Temperature-Sensitive Medications

Even medications that do not require refrigeration may have temperature restrictions:

• Do not exceed 77 degrees F (25 degrees C) -- cannot be left in hot cars, outdoor environments, or non-climate-controlled spaces
• Protect from freezing -- cannot be transported in vehicle trunks during winter
• Light-sensitive -- must be stored in original containers away from sunlight

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When a plaintiff is taking a refrigerated biologic for post-traumatic migraines, every trip away from home requires planning. They need an insulated travel case, cold packs, knowledge of the medication's stability outside refrigeration, and confirmation that their destination has refrigeration available. A spontaneous weekend away becomes a logistics exercise. Before the accident, they could grab a bag and go. Now, every departure requires pharmaceutical planning. That loss of spontaneity is a real quality-of-life impact that the pharmacy record documents."

Controlled Substance Travel Requirements

Domestic Travel

Traveling with DEA-scheduled controlled substances within the United States requires:

• Original pharmacy containers -- medications must be in the labeled prescription bottles with the patient's name, medication name, prescriber, and pharmacy
• Sufficient quantity only -- carrying quantities significantly exceeding the prescribed supply may raise law enforcement concerns
• TSA screening -- medications must be declared and may be inspected during airport security screening
• Documentation -- carrying a copy of the prescription or a letter from the prescriber is recommended

International Travel

International travel with controlled substances adds significant complexity:

• Import/export regulations -- each country has its own rules about which controlled substances can be brought in and in what quantities
• Advance notification -- some countries require advance notification or permits to bring controlled substances across their borders
• Quantity limits -- many countries limit the quantity of controlled substances to a 30-day supply or less
• Documentation requirements -- original prescriptions, prescriber letters, and sometimes consulate-stamped permits may be required
• DEA export permits -- under certain circumstances, transporting controlled substances internationally may require DEA notification

Impact on Travel Freedom

These requirements mean a plaintiff on controlled substances faces:

• Extended pre-travel preparation time (obtaining documentation, contacting consulates)
• Restricted destination options (countries with prohibitive controlled substance import rules)
• Increased risk of travel disruption (medications confiscated, detained at customs)
• Anxiety about medication availability if travel is extended unexpectedly

Injectable Medication Travel Burden

Plaintiffs who self-inject medications face additional travel restrictions:

• Sharps containers -- used needles and syringes must be collected in approved sharps disposal containers
• Sharps disposal at destination -- local sharps disposal locations must be identified in advance
• TSA and needle transport -- injectable medications with needles and syringes require additional screening at airport security
• International needle transport -- some countries restrict importation of syringes and needles; documentation of medical necessity may be required
• Injection supplies -- alcohol swabs, adhesive bandages, and other supplies must be packed

Using Storage and Travel Evidence in Demand Packages

When presenting storage and travel restriction evidence in demand packages:

1. List every medication with special storage requirements -- include the specific storage conditions from the package insert
2. Document controlled substance travel requirements -- outline the federal and state documentation requirements for each scheduled medication
3. Describe the pre-travel planning burden -- explain the steps the plaintiff must take before every trip
4. Contrast with pre-accident reality -- emphasize that the plaintiff faced none of these restrictions before the injury
5. Quantify the restriction -- identify specific activities, destinations, or types of travel that are now restricted or eliminated

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes medication storage and travel impact analysis.

Countering Defense Arguments

"These restrictions are minor inconveniences."

Medication storage and travel requirements are not minor when they eliminate spontaneous travel, restrict international destinations, require hours of pre-travel preparation, and create anxiety about medication availability. The cumulative burden across multiple medications with different storage and travel requirements compounds the impact on daily living.

"The plaintiff can still travel."

The plaintiff can travel, but with significant restrictions, advance planning, and logistical burdens they did not face before the accident. The question is not whether travel is impossible but whether it has been materially burdened by the injury and its pharmacological treatment. The storage and documentation requirements objectively demonstrate that burden.

"These are standard requirements for anyone on medication."

The relevant comparison is to the plaintiff's own pre-accident life, not to a hypothetical population. If the plaintiff had no medications requiring special storage or travel documentation before the accident, every restriction is attributable to the injury. The pharmacy record documents the transition from zero medication-related travel restrictions to their current burden.

Practical Takeaways

Medication storage and travel restrictions are concrete, documentable quality-of-life impacts that flow directly from the injury and its pharmacological treatment. Refrigeration requirements, temperature controls, controlled substance documentation, and injectable supply management all restrict the plaintiff's freedom of movement and spontaneity in ways that can be objectively described and verified through pharmacy records and federal regulations. Attorneys who present these restrictions as damages evidence show the jury a dimension of the plaintiff's daily reality that is often invisible in traditional case presentations.

Related Resources

• Pill Burden and Daily Medication Schedule as Damages -- Quantifying daily medication events
• Visual Medication Evidence: Photos and Pill Organizers -- Creating visual evidence of medication burden
• Polypharmacy Burden as a Damages Element -- Multi-medication burden as damages